As a result of the tender offer, Life Corporation has decided to acquire ALBIS Co.,Ltd. shares; the total number of tendered shares, 6,045,556 shares, exceeded the purchase lower limit and the offer was successful. The settlement start date is 2026-11-17. Consequently, ALBIS will become a consolidated subsidiary of Life Corporation and proceed with delisting procedures. There will be changes among major shareholders and their affiliates, and a squeeze-out procedure is planned.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7475","jir_company_name":"ALBIS Co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7475-20261111-01.pdf","jir_short_summary":"As a result of the tender offer, Life Corporation has decided to acquire ALBIS Co.,Ltd. shares; the total number of tendered shares, 6,045,556 shares, exceeded the purchase lower limit and the offer was successful. The settlement start date is 2026-11-17. Consequently, ALBIS will become a consolidated subsidiary of Life Corporation and proceed with delisting procedures. There will be changes among major shareholders and their affiliates, and a squeeze-out procedure is planned.","jir_summary":"### Completion of the TOB and Purchase Details\nThe tender offer by Life Corporation for ALBIS Co.,Ltd. shares was successful as the total number of tendered shares exceeded the lower limit of the planned purchases. The offer period ran from 2026-09-09 to 2026-11-10 (40 business days), and the purchase price was 3,780 yen per common share. The maximum number of shares to be purchased was 6,966,769 shares, with a lower limit of 4,171,200 shares. The settlement start date is 2026-11-17. After the TOB is completed, ALBIS will become a consolidated subsidiary of Life Corporation and proceed with delisting procedures.\n\n### Next Steps and Impact\nFollowing the successful tender offer, procedures to change the registered holders (including a squeeze-out) are planned. The effective date for changes is scheduled as 2026-11-17 (settlement start date). After delisting, ALBIS shares are expected to cease trading on the Tokyo Stock Exchange Prime Market. The offeror and non-tendering agreed shareholders will promptly disclose subsequent procedures.","jir_financial_highlights":"Planned number of shares to be purchased: 6,966,769 shares\nLower limit of planned purchases: 4,171,200 shares\nTotal number of tendered shares: 6,045,556 shares (No upper limit)\nPurchase price: 3,780 yen\nSettlement start date: 2026-11-17","jir_category":"","jir_hashtags":"#ALBIS, #TOB, #Subsidiarization, #Delisting","jir_key_figures":"Purchase price: 3,780 yen\nNumber of shares to be purchased: 6,966,769 shares (maximum)\nSettlement start date: 2026-11-17","jir_meta_title":"ALBIS: Results of Tender Offer and Changes in Parent and Major Shareholders | November 2026","jir_meta_description":"Announcement of the tender offer results for ALBIS Co.,Ltd. Total tendered shares were 6,045,556 shares; purchase price 3,780 yen; offer successful. Settlement begins on 2026-11-17. Delisting to follow via squeeze-out procedures.","jir_og_title":"ALBIS: Tender Offer Results and Notice of Changes | November 2026","jir_og_description":"Notice of the tender offer results by Life Corporation. Details on completion, settlement start date, delisting plan, and subsequent procedures are provided.","jir_og_image_url":"\/assets\/og\/company-tender_offer.jpg","jir_chart_data_collection":"[]","ir_related_company":57567,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-149296","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n